Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980035/S848

Astra S DR MRI IPG (X3DR01); Astra S SR MRI IPG (X3SR01); Astra XT DR MRI IPG (X1DR01); Astra XT SR MRI IPG (X1SR01); Az

Medtronic, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP980035/S848

What did the FDA decide?

FDA recorded a 30-Day Notice decision (OK30) dated 2026-10-23 for PMA supplement P980035/S848 from Medtronic, Inc., covering Astra S DR MRI IPG (X3DR01), Astra S SR MRI IPG (X3SR01), Astra XT DR MRI IPG (X1DR01), Astra XT SR MRI IPG (X1SR01) and additional Astra models named in the truncated title. The device category is permanent implantable pulse generator, cardiovascular specialty, product code NVZ.

The recorded scope is a manufacturing process change: introduction of a second Medium Rate (MR) Headers manufacturing line and inspection updates to the MR Headers Line currently in production, filed under Process Change - Manufacturer/Sterilizer/Packager/Supplier. This supplement concerns header production, not a new approval of the full generator system. The source lists no supporting documents, so inspection methods, line qualification data and any effect on finished-device specifications remain unknown.

The OK30 code and the absence of linked documents leave the basis for the decision unstated here; no clinical, performance or labeling conclusions follow from this record.

FDA approval order statement

the introduction of a second Medium Rate (MR) Headers manufacturing line and to make inspection updates to the MR Headers Line that is currently in production
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980035/S848
Regulatory pathway
PMA supplement
Product code
NVZ
Decision code
OK30
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, permanent, implantable.

Product code
NVZ
FDA device class
3

For the original device and its historical approval scope, see PMA P980035. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980035 · Original PMA

    MEDTRONIC KAPPA 700/600 SERIES PULSE GENERATORS AND MODEL 9953 SOFTWARE

  2. P980035/S848 received

    Application receipt date recorded by FDA.

  3. P980035/S847 · Related supplement

    Astra S DR MRI IPG, Astra S SR MRI IPG, Astra XT SR MRI IPG, Azure S DR MRI IPG, Azure S SR MRI IPG, Azure XT DR MRI IPG

  4. P980035/S848 · FDA decision

    30-Day Notice

  5. P980035/S849 · Related supplement

    Astra S DR MRI IPG; Astra S SR MRI IPG; Astra XT DR MRI IPG; Astra XT SR MRI IPG; Azure S DR MRI IPG; Azure S SR MRI IPG

Timeline entries are records held by MedtechLedger for P980035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980035

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records